Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Batch Consistency Study of Bio Farma DTP/HB/Hib Vaccine in Infants
NCT01986335Phase 3Completed
- Sponsor
- Bio Farma
- Start
- Aug 2012
- Primary completion
- Jan 2013
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of diphtheria, tetanus, pertussis (whole cell), hepatitis B and haemophilus influenzae type b vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by Bio Farma. Started Aug 2012; status: completed.
02
Drugs
diphtheria, tetanus, pertussis (whole cell), hepatitis B and haemophilus influenzae type b vaccine
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01986335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01986335.